ANA 2021: The PPARγ Agonist Leriglitazone Reduces Several Measures of Adrenomyeloneuropathy
Imaging and biochemical parameters in plasma of this metabolite of pioglitazone were explored.
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.